These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33391852)

  • 1. Aztreonam and Vancomycin for Initial Treatment of Febrile Neutropenia in Penicillin-Allergic Patients During Hematopoietic Stem Cell Transplantation.
    Trifilio S; Mehta J
    J Adv Pract Oncol; 2019; 10(7):685-690. PubMed ID: 33391852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aztreonam for febrile neutropenia in patients with beta-lactam allergy.
    McCullough BJ; Wiggins LE; Richards A; Klinker K; Hiemenz JW; Wingard JR
    Transpl Infect Dis; 2014 Feb; 16(1):145-52. PubMed ID: 24119095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of Chemotherapy-Induced Febrile Neutropenic Episodes Into One of the Three Febrile Neutropenic Syndromes.
    Raheja R; Reddy N; Patel T; Kilambi S; Mathew AA; Majeed A
    Cureus; 2023 Aug; 15(8):e42843. PubMed ID: 37664262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aztreonam plus vancomycin (plus amikacin) vs. moxalactam plus ticarcillin for the empiric treatment of febrile episodes in neutropenic cancer patients.
    Jones P; Rolston K; Fainstein V; Elting L; Bodey GP
    Rev Infect Dis; 1985; 7 Suppl 4():S741-6. PubMed ID: 3909332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
    Raad II; Whimbey EE; Rolston KV; Abi-Said D; Hachem RY; Pandya RG; Ghaddar HM; Karl CL; Bodey GP
    Cancer; 1996 Apr; 77(7):1386-94. PubMed ID: 8608520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating Initial Empiric Therapy for Neutropenic Fever in Vancomycin-Resistant Enterococcus-Colonized Patients.
    Snyder M; Pasikhova Y; Baluch A
    Cancer Control; 2021; 28():10732748211045593. PubMed ID: 34558349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention and treatment of febrile neutropenia].
    Montemurro F; Gallicchio M; Aglietta M
    Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and safety of vancomycin versus teicoplanin in febrile neutropenic patients receiving hematopoietic stem cell transplantation.
    Kato-Hayashi H; Niwa T; Ohata K; Harada S; Matsumoto T; Kitagawa J; Tsurumi H; Suzuki A
    J Clin Pharm Ther; 2019 Dec; 44(6):888-894. PubMed ID: 31373043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy.
    Link H; Maschmeyer G; Meyer P; Hiddemann W; Stille W; Helmerking M; Adam D
    Ann Hematol; 1994 Nov; 69(5):231-43. PubMed ID: 7948312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
    Eleutherakis-Papaiakovou E; Kostis E; Migkou M; Christoulas D; Terpos E; Gavriatopoulou M; Roussou M; Bournakis E; Kastritis E; Efstathiou E; Dimopoulos MA; Papadimitriou CA
    Am J Hematol; 2010 Nov; 85(11):863-7. PubMed ID: 20882526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
    Mustafa MM; Carlson L; Tkaczewski I; McCracken GH; Buchanan GR
    Pediatr Infect Dis J; 2001 Mar; 20(3):362-9. PubMed ID: 11303851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous stem cell transplantation].
    Zikesoá E; Hnátková M; Vacková B; Jedlicková A; Klener P; Trnený M
    Cas Lek Cesk; 2006; 145(5):383-6, 388-9. PubMed ID: 16755776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Empiric Treatment for Vancomycin-Resistant Enterococcus in Colonized Patients Early after Allogeneic Hematopoietic Stem Cell Transplantation.
    Kamboj M; Cohen N; Huang YT; Kerpelev M; Jakubowski A; Sepkowitz KA; Papanicolaou GA; Seo SK
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):594-598. PubMed ID: 30448456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.
    Bossaer JB; Hall PD; Garrett-Mayer E
    Support Care Cancer; 2010 Feb; 19(2):231-7. PubMed ID: 20069435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome.
    Niessen FA; van Mourik MSM; Bruns AHW; Raijmakers RAP; de Groot MCH; van der Bruggen T
    Antimicrob Resist Infect Control; 2020 May; 9(1):74. PubMed ID: 32460887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation.
    Ortega M; Rovira M; Filella X; Almela M; Puig de la Bellacasa J; Carreras E; Mensa J
    Br J Haematol; 2004 Aug; 126(3):372-6. PubMed ID: 15257709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes].
    Figuera A; Tomás JF; Hernández L; Jiménez ML; Peñarrubia MJ; del Rey MC; Arranz R; Cámara R; López-Lorenzo JL; Fernández-Rañada JM
    Rev Clin Esp; 1996 Aug; 196(8):515-22. PubMed ID: 8984537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low utilization of vancomycin in febrile neutropenia: real-world evidence from 4 Brazilian centers.
    Ramos JF; Pereira AD; Seiwald MCN; Gandolpho LS; Molla VC; Guaraná M; Nouér SA; Nucci M; Rodrigues CA
    Support Care Cancer; 2023 Nov; 31(12):687. PubMed ID: 37947888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
    Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
    Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer.
    Chuang YY; Hung IJ; Yang CP; Jaing TH; Lin TY; Huang YC
    Pediatr Infect Dis J; 2002 Mar; 21(3):203-9. PubMed ID: 12005083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.